Does escitalopram (Lexapro) cause dizziness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Lexapro Cause Dizziness?

Yes, Lexapro (escitalopram) does cause dizziness as a recognized adverse effect, occurring in approximately 5% of patients during active treatment and more commonly (10-44%) during discontinuation. 1

Dizziness During Active Treatment

The FDA-approved prescribing information clearly lists dizziness as an adverse reaction occurring in 5% of patients treated with Lexapro compared to 3% with placebo in major depressive disorder trials 1. This represents a modest but statistically significant increase over placebo. In generalized anxiety disorder trials, dizziness was also reported, though specific percentages varied by patient population 2.

Key Clinical Context:

  • Dizziness is among the common side effects alongside nausea (15%), insomnia (9%), and fatigue (5%) 1
  • The incidence appears dose-dependent, with higher rates at 20 mg/day compared to 10 mg/day 1
  • In pediatric patients (7-17 years), dizziness occurred in 3% on escitalopram versus 2% on placebo 1

Dizziness During Discontinuation (More Significant Risk)

The more clinically important concern is discontinuation-related dizziness, which occurs far more frequently and can be quite pronounced. When escitalopram is stopped abruptly, dizziness becomes one of the most common discontinuation symptoms 1, 3.

Discontinuation Syndrome Characteristics:

  • Dizziness occurred in 44% of patients experiencing antidepressant discontinuation syndrome after stopping escitalopram 3
  • During tapered withdrawal in clinical trials, dizziness still affected 10-12% of patients 4
  • The dizziness is exacerbated by head movement, suggesting vestibular origin related to sudden serotonin changes in the vestibular nucleus complex 5
  • Higher doses and plasma concentrations of escitalopram increase the risk of discontinuation syndrome 3

Critical Clinical Pitfall:

The FDA label explicitly warns about discontinuation syndrome, stating: "Suddenly stopping Lexapro may cause you or your child to have serious side effects" including dizziness, headache, confusion, and electric shock sensations 1. Very slow tapering is recommended for all patients to minimize these effects 3.

Clinical Recommendations

When prescribing escitalopram:

  • Inform patients that mild dizziness (5% incidence) may occur during treatment
  • Never allow abrupt discontinuation - always taper slowly
  • Monitor closely in the first 1-2 weeks of treatment when side effects are most likely 6
  • Consider starting at lower doses (5-10 mg) to minimize initial side effects
  • Be particularly cautious in elderly patients who may be more susceptible to dizziness and falls 2

If dizziness occurs during treatment:

  • Assess whether it's related to orthostatic changes (though escitalopram is not typically associated with orthostatic hypotension) 1
  • Consider dose reduction if dizziness is bothersome
  • Rule out drug interactions with other medications that may potentiate dizziness

When discontinuing escitalopram:

  • Taper the dose gradually over weeks to months, especially in patients on higher doses or with longer treatment duration 3
  • Warn patients specifically about potential dizziness during tapering
  • If severe discontinuation symptoms occur, consider resuming the medication and tapering more slowly

The evidence consistently demonstrates that while dizziness during active escitalopram treatment is relatively modest (5%), the risk during discontinuation is substantially higher and clinically more problematic, making proper tapering essential 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.